China News Service, January 19 According to foreign media reports on the 19th, in order to curb the spread of the new crown epidemic, Saudi Arabia is actively promoting the large-scale vaccination of the new crown vaccine.
According to the latest news, the Saudi Ministry of Health has approved the use of the new crown vaccine developed by the pharmaceutical companies AstraZeneca and Modena.
Prior to this, Saudi Arabia has begun to vaccinate the new crown vaccine developed by Pfizer.
Data map: Pfizer vaccine.
Photo by China News Agency reporter Liao Pan
Ibrahim Olayfi, the director-general of health affairs in the Eastern Province of Saudi Arabia, said that there is global competition for existing vaccine supplies, and the demand for Pfizer vaccines is "large."
However, the Saudi authorities have ensured that sufficient vaccines are available and are stepping up vaccination efforts.
He said that in the Eastern Province, about 400,000 people have registered through the health service application launched by the Ministry of Health, expressing their desire to be vaccinated, and about 60,000 people have already been vaccinated.
In the first month after the start of the vaccine registration process, more than 2 million people across the country registered and hoped to receive the vaccine.
According to reports, according to statistics from the past month, the Saudi Ministry of Health currently receives 100,000 doses of Pfizer vaccine every week.